mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.32 |
0.3 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |